c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis

Journal of Clinical Investigation

Volumn 108, Issue 1, 2001, Pages 73-81

  Han, Z ^a   Boyle, D L ^a   Chang, L ^a   Bennett, B ^a   Karin, M ^a   Yang, L ^a   Manning, A M ^a   Firestein, G S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; COLLAGENASE 3; INTERLEUKIN 1; METALLOPROTEINASE; PROTEIN KINASE INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANIMAL CELL; ANIMAL MODEL; ARTHRITIS; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; INFLAMMATORY DISEASE; JOINT DESTRUCTION; JOINT RADIOGRAPHY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; SYNOVIOCYTE;

EID: 0034931503     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI12466     Document Type: Article

References (36)

1. Mitogen-activated protein kinase pathways
2. The MAPK signaling cascade
3. MEKKs, GCKs, MLKs, PAKs, TAKs, and tpls: Upstream regulators of the c-Jun amino-terminal kinases?
4. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain
5. Rheumatoid arthritis
6. Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium. Quantitative analysis and effect of intraarticular corticosteroids
7. The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases
8. JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation
9. Jun-N terminal kinase in rheumatoid arthritis
10. Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes
11. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
12. JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development
13. AP-1 and NF-kB regulation in rheumatoid arthritis and murine collagen-induced arthritis
14. Anti-inflammatory effects of ABT-702, a novel non-nucleoside adenosine kinase inhibitor, in rat adjuvant arthritis
15. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway
16. The regulation of AP-I activity by mitogen-activated protein kinases
17. Mechanisms of tissue destruction and cellular activation in rheumatoid arthritis
18. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor
19. The stress-activated protein kinase pathways
20. JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation
21. c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases
22. Selective interaction of JNK protein kinase isoforms with transcription factors
23. Signal transduction and transcription factors in rheumatic disease
24. Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis
25. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: Differential regulation of collagenase 1 and collagenase 3
26. Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion
27. Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways
28. Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: Regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels
29. Defective T cell differentiation in the absence of Jnk1
30. Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2
31. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases
32. NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint
33. NF-κB regulation by IκB kinase in primary fibroblast-like synoviocytes
34. NF-κB: A key role inflammatory diseases